Status:
UNKNOWN
Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus
Lead Sponsor:
Fujian Provincial Hospital
Conditions:
Pneumonia Caused by Human Coronavirus
Eligibility:
All Genders
18-75 years
Brief Summary
Objects: The purpose of this study was to observe the characteristics of morbidity, disease progression and therapeutic effects of 2019-novel coronavirus pneumonia patients with different clinical typ...
Detailed Description
Since December 2019, patients with unexplained pneumonia have appeared in some medical institutions in Wuhan, China. Nucleic acid testing was completed on January 10, 2020, which was confirmed to be c...
Eligibility Criteria
Inclusion
- Inclusion criteria.
- 2019-nCov (SARA-Cov-2) nucleic acid positive detected by PCR.
- Older than 18 years old and younger than 75 years old.
- Meet the diagnostic criteria of COVID-19 for different types (including ordinary type, heavy type and critical type)
- Exclusion criteria.
- the age is less than 18 years old;
- pregnant or lactating women;
- severe underlying diseases, such as advanced malignant tumor, end-stage lung disease, etc.
Exclusion
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04292327
Start Date
January 1 2020
End Date
July 31 2020
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Provincial Hospital
Fuzhou, Fujian, China, 350000